47.71
price up icon0.44%   0.21
after-market Dopo l'orario di chiusura: 47.71
loading
Precedente Chiudi:
$47.50
Aprire:
$46.92
Volume 24 ore:
2.41M
Relative Volume:
1.16
Capitalizzazione di mercato:
$119.62B
Reddito:
$53.04B
Utile/perdita netta:
$4.93B
Rapporto P/E:
15.03
EPS:
3.1735
Flusso di cassa netto:
$9.91B
1 W Prestazione:
+1.94%
1M Prestazione:
-0.15%
6M Prestazione:
+1.84%
1 anno Prestazione:
-1.04%
Intervallo 1D:
Value
$46.89
$47.90
Intervallo di 1 settimana:
Value
$45.80
$49.73
Portata 52W:
Value
$45.22
$58.97

Sanofi Adr Stock (SNY) Company Profile

Name
Nome
Sanofi Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
87,994
Name
Cinguettio
@sanofi
Name
Prossima data di guadagno
2024-10-25
Name
Ultimi documenti SEC
Name
SNY's Discussions on Twitter

Confronta SNY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
47.71 119.62B 53.04B 4.93B 9.91B 1.9736
Drug Manufacturers - General icon
LLY
Lilly Eli Co
767.76 690.46B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
85.00 377.54B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
144.47 347.83B 87.70B 14.68B 19.03B 6.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
175.58 310.27B 55.53B 5.12B 15.62B 2.88
Drug Manufacturers - General icon
MRK
Merck Co Inc
98.05 248.03B 63.17B 12.15B 14.84B 4.77

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-26 Reiterato Argus Buy
2024-01-23 Iniziato Morgan Stanley Equal-Weight
2024-01-16 Ripresa UBS Buy
2023-12-05 Downgrade JP Morgan Overweight → Neutral
2023-10-30 Downgrade Stifel Buy → Hold
2023-09-06 Aggiornamento Berenberg Hold → Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-04-28 Downgrade Deutsche Bank Hold → Sell
2023-03-27 Aggiornamento Barclays Equal Weight → Overweight
2022-12-13 Ripresa Morgan Stanley Overweight
2022-08-12 Aggiornamento Deutsche Bank Sell → Hold
2022-08-09 Downgrade UBS Buy → Neutral
2022-05-23 Iniziato SVB Leerink Outperform
2021-09-27 Aggiornamento SVB Leerink Mkt Perform → Outperform
2021-01-15 Iniziato Deutsche Bank Sell
2020-09-29 Iniziato Berenberg Hold
2020-03-17 Aggiornamento Barclays Underweight → Equal Weight
2020-03-11 Aggiornamento Goldman Neutral → Buy
2020-02-11 Iniziato SVB Leerink Mkt Perform
2020-01-06 Aggiornamento JP Morgan Neutral → Overweight
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
2019-09-20 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-09-03 Iniziato Bernstein Outperform
2019-08-14 Aggiornamento UBS Neutral → Buy
2018-12-11 Aggiornamento Jefferies Hold → Buy
2018-11-01 Aggiornamento Barclays Underweight → Equal Weight
2018-10-09 Iniziato Guggenheim Neutral
2018-09-10 Aggiornamento BofA/Merrill Neutral → Buy
2018-08-10 Aggiornamento Citigroup Neutral → Buy
2018-03-23 Aggiornamento Liberum Hold → Buy
2018-01-23 Downgrade Barclays Equal Weight → Underweight
2017-12-06 Downgrade BofA/Merrill Buy → Neutral
2017-12-01 Downgrade Morgan Stanley Overweight → Underweight
2017-11-15 Aggiornamento Barclays Underweight → Equal Weight
2017-08-30 Aggiornamento HSBC Securities Reduce → Hold
Mostra tutto

Sanofi Adr Borsa (SNY) Ultime notizie

pulisher
Dec 19, 2024

Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.

Dec 19, 2024
pulisher
Dec 19, 2024

Communiqué de presse - GlobeNewswire Inc.

Dec 19, 2024
pulisher
Dec 18, 2024

10 Best Blue-Chip Stocks to Buy for the Long Term - Morningstar

Dec 18, 2024
pulisher
Dec 17, 2024

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily

Dec 17, 2024
pulisher
Dec 17, 2024

What Did We Find About Insider Trading At Sanofi ADR (NASDAQ: SNY)? - Stocks Register

Dec 17, 2024
pulisher
Dec 16, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 16, 2024
pulisher
Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - MSN

Dec 12, 2024
pulisher
Dec 06, 2024

Top-3 International Stocks Beating Their U.S. Peers for Dividend Earnings - TheStreet

Dec 06, 2024
pulisher
Dec 03, 2024

Novo Nordisk and AstraZeneca top 2025 drug picks for US investment bankread why - Proactive Investors USA

Dec 03, 2024
pulisher
Nov 30, 2024

Why Sanofi (SNY) Is One of the Best ADR Stocks to Invest in? - Insider Monkey

Nov 30, 2024
pulisher
Nov 29, 2024

12 Best ADR Stocks To Invest In According to Analysts - Insider Monkey

Nov 29, 2024
pulisher
Nov 06, 2024

T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - GlobeNewswire Inc.

Nov 06, 2024
pulisher
Nov 06, 2024

How Robert F. Kennedy Jr. Will Bring Major Uncertainties to U.S. Healthcare - Barron's

Nov 06, 2024
pulisher
Oct 30, 2024

Sanofi Cancels Consumer Healthcare Business Spin-Off - Forbes

Oct 30, 2024
pulisher
Oct 30, 2024

Here’s Why Mastercard Incorporated (NYSE: MA) Is An Attractive Investment Right Now - Stocks Register

Oct 30, 2024
pulisher
Oct 28, 2024

Sanofi (SNY) Stock Price, News, Quote & History - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

16 New 4-Star Stocks - Morningstar

Oct 28, 2024
pulisher
Oct 28, 2024

Biggest stock movers Monday: DJT, crypto stocks, and more - MSN

Oct 28, 2024

Sanofi Adr Azioni (SNY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general BMY
$57.33
price up icon 1.83%
$263.38
price up icon 0.84%
drug_manufacturers_general PFE
$26.36
price up icon 2.29%
drug_manufacturers_general NVS
$97.11
price up icon 0.35%
drug_manufacturers_general MRK
$98.05
price down icon 1.48%
Capitalizzazione:     |  Volume (24 ore):